---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

IMAI Medtech

🌎 imai-medtech.com

IMAI Medtech is a pioneering company focused on revolutionizing oncology diagnostics through its innovative 3D histology technology. The company specializes in rapid and automated tissue preparation, enabling early and accurate cancer diagnosis, which enhances therapeutic outcomes and improves patient care. IMAI's solutions aim to eliminate the limitations of traditional 2D histology by providing complete quantification of biopsies and supporting pathologists with advanced digital imaging and algorithms.

---

IMAI Medtech - Latest News and Updates

• IMAI Medtech is launching a clinical validation study comparing 3D and 2D cancer diagnostics using advanced 3D histology automation and machine learning.
• Francesca Catto, CEO of IMAI Medtech, pitched at the Bluelion Incubator event on November 29.
• IMAI Medtech, co-founded by Francesca Catto, is developing a robotic platform for 3D histopathology to improve cancer diagnosis.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.